{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:49:44Z","timestamp":1790812184541,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T00:00:00Z","timestamp":1471219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7-HEALTH-2011.1.4-4-280873"],"award-info":[{"award-number":["FP7-HEALTH-2011.1.4-4-280873"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (US)","doi-asserted-by":"crossref","award":["AI 105422"],"award-info":[{"award-number":["AI 105422"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0161217","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T13:32:59Z","timestamp":1471267979000},"page":"e0161217","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis"],"prefix":"10.1371","volume":"11","author":[{"given":"Rolf","family":"Billeskov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esterlina V.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Cang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo M.","family":"Abalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Vestergaard","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else Marie","family":"Agger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,15]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-2600(14)70033-5","article-title":"Progress in tuberculosis vaccine development and host-directed therapies\u2014a state of the art review","volume":"2","author":"SH Kaufmann","year":"2014","journal-title":"Lancet Resp Med"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018523","article-title":"Novel vaccination strategies against tuberculosis","volume":"4","author":"P Andersen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9871","key":"ref3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"MD Tameris","year":"2013","journal-title":"Lancet"},{"key":"ref4","article-title":"Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial","author":"BP Ndiaye","year":"2015","journal-title":"Lancet Resp Me"},{"issue":"30","key":"ref5","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"HW Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.4049\/jimmunol.1400019","article-title":"Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells","volume":"192","author":"S Sakai","year":"2014","journal-title":"J Immunol"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"e72185","DOI":"10.1371\/journal.pone.0072185","article-title":"Comparing adjuvanted H28 and modified vaccinia virus ankara expressingH28 in a mouse and a non-human primate tuberculosis model","volume":"8","author":"R Billeskov","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201003-0334OC","article-title":"Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns","volume":"182","author":"BM Kagina","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1128\/IAI.00287-09","article-title":"Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis","volume":"77","author":"HM Vordermeier","year":"2009","journal-title":"Infect Immun"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/IAI.02086-05","article-title":"High Frequency of CD4+ T Cells Specific for the TB10.4 Protein Correlates with Protection against Mycobacterium tuberculosis Infection","volume":"74","author":"S Hervas-Stubbs","year":"2006","journal-title":"Infect Immun"},{"issue":"48\u201349","key":"ref11","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1016\/j.vaccine.2005.07.037","article-title":"Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guerin induced protection against Mycobacterium bovis","volume":"23","author":"KE Logan","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"FA Verreck","year":"2009","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"JL Flynn","year":"1993","journal-title":"J Exp Med"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"C Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"C Aagaard","year":"2011","journal-title":"Nat Med"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"e80579","DOI":"10.1371\/journal.pone.0080579","article-title":"ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination","volume":"8","author":"T Hoang","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"PL Lin","year":"2012","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"ref18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbamem.2005.10.011","article-title":"Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses","volume":"1718","author":"J Davidsen","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.4049\/jimmunol.0804091","article-title":"Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-Guerin","volume":"183","author":"CA Andersen","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejpb.2010.10.001","article-title":"Incorporation of a synthetic mycobacterial monomycoloyl glycerol analogue stabilizes dimethyldioctadecylammonium liposomes and potentiates their adjuvant effect in vivo","volume":"77","author":"P Nordly","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00262-011-1156-6","article-title":"CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice","volume":"61","author":"J Hansen","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jconrel.2010.11.021","article-title":"Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method","volume":"150","author":"P Nordly","year":"2011","journal-title":"J Control Release"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"H Yu","year":"2012","journal-title":"Infect Immun"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4049\/jimmunol.182.1.424","article-title":"A simple mycobacterial monomycolated glycerol lipid has potent immunostimulatory activity","volume":"182","author":"CS Andersen","year":"2009","journal-title":"J Immunol"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/IAI.00064-06","article-title":"Early events in Mycobacterium tuberculosis infection in cynomolgus macaques","volume":"74","author":"PL Lin","year":"2006","journal-title":"Infect Immun"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/IAI.00592-09","article-title":"Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model","volume":"77","author":"PL Lin","year":"2009","journal-title":"Infect Immun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nm0496-430","article-title":"The Phillipine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease","volume":"2","author":"GP Walsh","year":"1996","journal-title":"Nat Med"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-0684.2012.00536.x","article-title":"The non-human primate model of tuberculosis","volume":"41","author":"D Kaushal","year":"2012","journal-title":"J Med Primatol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"e1004603","DOI":"10.1371\/journal.ppat.1004603","article-title":"Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization","volume":"11","author":"HP Gideon","year":"2015","journal-title":"PLoS Pathog"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00079-10","article-title":"Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing","volume":"17","author":"SA Sharpe","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"20","key":"ref31","doi-asserted-by":"crossref","first-page":"11497","DOI":"10.1073\/pnas.201404898","article-title":"Divergent effect of bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research","volume":"98","author":"JA Langermans","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/IAI.02850-14","article-title":"Monkey models of tuberculosis: lessons learned","volume":"83","author":"JC Pena","year":"2015","journal-title":"Infect Immun"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nm.3105","article-title":"Persistent antigen at vaccination sites induces tumor-specific CD8(+) T cell sequestration, dysfunction and deletion","volume":"19","author":"Y Hailemichael","year":"2013","journal-title":"Nat Med"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2009.10.022","article-title":"Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen","volume":"142","author":"M Henriksen-Lacey","year":"2010","journal-title":"J Control Release"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.4049\/jimmunol.1300248","article-title":"Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells","volume":"190","author":"T Lindenstrom","year":"2013","journal-title":"J Immunol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/jiv055","article-title":"Interferon gamma and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis","volume":"212","author":"MT Orr","year":"2015","journal-title":"J Infect Dis"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.it.2014.04.006","article-title":"Tuberculosis vaccines\u2014rethinking the current paradigm","volume":"35","author":"P Andersen","year":"2014","journal-title":"Trends Immunol"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"e1002052","DOI":"10.1371\/journal.ppat.1002052","article-title":"A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo","volume":"7","author":"AM Gallegos","year":"2011","journal-title":"PLoS Pathog"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"T Lindenstrom","year":"2009","journal-title":"J Immunol"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"e5930","DOI":"10.1371\/journal.pone.0005930","article-title":"Protection and polyfunctional T cells induced by Ag85B-TB10.4\/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose","volume":"4","author":"C Aagaard","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1128\/IAI.68.2.621-629.2000","article-title":"CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in mice","volume":"68","author":"P Andersen","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"RA Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.3412","article-title":"Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing","volume":"20","author":"PL Lin","year":"2014","journal-title":"Nat Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0161217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:17:36Z","timestamp":1540336656000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0161217"}},"subtitle":[],"editor":[{"given":"Angelo A.","family":"Izzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,15]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0161217","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,15]]}}}